APELOA

同壁财经 · May 30 at 10:02 AM

APELOA has continuously received a Wind ESG BBB rating, with a comprehensive score of 6.50

Yicai · Apr 22 at 03:46 AM

Chinese API Suppliers Pass On Higher Raw Material Costs Arising From Mideast War

Wallstreetcn · Mar 25 at 08:35 PM

Innovative drug concept stocks continue to be strong, with Menovo hitting a 3-day consecutive limit up, followed by Fushine, BHC, Kingchem, APELOA, and WuXi AppTec

Zhitong · Nov 3, 2025 at 03:39 AM

APELOA has repurchased a total of 10.06 million shares at a cost of 144 million yuan

Zhitong · Oct 31, 2025 at 02:55 AM

APELOA's subsidiary has obtained the drug registration certificate for L-carnitine injection

Zhitong · Oct 21, 2025 at 04:00 AM

APELOA released its performance for the first three quarters, with a net profit attributable to the parent company of 700 million yuan, a decrease of 19.48%